Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G for VERONA PHARMA PLC American Depositary Shares (VRNA).
- Disclosed ownership: 6.5%.
- Date of event: 31 Mar 2025.
JANUS HENDERSON GROUP PLC - 31 Mar 2025 SCHEDULE 13G Report for VERONA PHARMA PLC American Depositary Shares (VRNA)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Symbol
- VRNA
- Shares outstanding
- 85,221,677 shares
- Disclosed Ownership
- 5,539,409 shares
- Ownership
- 6.5%
- Form type
- SCHEDULE 13G
- Filing time
- 14 May 2025, 11:47:19 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 6.5% ownership in VERONA PHARMA PLC American Depositary Shares (VRNA) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 May 2025, 11:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 6.5% | 5,539,409 | 0 | 5,539,409 | Kristin Mariani | Head of North America Compliance, CCO |